Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Kinnon

Premium

Transgenomic has appointed Paul Kinnon to president and CEO, replacing Craig Tuttle. Kinnon will also serve as a director on the company's board. He previously provided commercial and strategic consultancy services to Transgenomics and other life science companies. He was also CEO of ZyGem and previously held positions at Invitrogen, Guava Technologies, and Cellomics.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.